“The Double-Dare of Cholesterol: Why Indian Patients Need Both LDL and ApoB to Outwit Heart & Kidney Risk ”. Diabzen 3, no. 2 (November 15, 2025): 35–38. Accessed February 27, 2026. https://www.thediabzen.com/index.php/d/article/view/17.